RT Banner 2021V4.gif

China Daily

News> Hong Kong> Content
Thursday, February 25, 2021, 22:39
WeDoctor's HK IPO looms with 'valuation near US$7 billion'
By Bloomberg
Thursday, February 25, 2021, 22:39 By Bloomberg

A visitor is seen at the stand of Chinese online healthcare solutions platform WeDoctor, which is backed by Tencent Holdings, during the fourth World Internet Conference (WIC) at the Wuzhen International Internet Exhibition & Convention Center in Wuzhen town, Jiaxing city, east China's Zhejiang province, Dec 4, 2017. (PHOTO / IMAGINECHINA VIA AP)

WeDoctor is planning to file for an initial public offering in Hong Kong as soon as next month after fetching a valuation of US$6.8 billion in its latest funding round, according to people familiar with the matter.

The Tencent Holdings Ltd-backed company raised about US$400 million in a pre-IPO round at the end of last year, according to people familiar with the matter

The Tencent Holdings Ltd-backed company raised about US$400 million in a pre-IPO round from investors including Sequoia Capital China and Millennium Management LLC at the end of last year, the people said. The company is in the process of hiring joint global coordinators, paving the way for a filing in as early as March, said the people, requesting not to be named because the matter is private.

Jeff Chen rejoined the company as chief strategy officer looking after capital markets and the listing process following a stint at Singapore’s Fullerton Healthcare Corp, they added.

ALSO READ: Tencent-backed WeDoctor 'eyes US$1 billion Hong Kong IPO'

WeDoctor is part of a growing contingent of technology giants trying to transform the Chinese mainland’s healthcare system. In preparation for the listing, the Hangzhou-based company is splitting its business into two parts, with plans to list its healthcare services operations, which include online and on-the-ground consulting, people familiar have said.

Its more sensitive data business that handles personal medical records will be spun off and kept private to comply with regulatory demands.

WeDoctor declined to comment on its fundraising and IPO plans in an emailed statement. It declined to comment on behalf of Chen. Sequoia Capital China declined to comment in an email. A New York-based spokesman for Millennium didn’t immediately respond to an email seeking comment late Wednesday local time.

Citigroup Inc along with JPMorgan Chase & Co and CMB International Securities Ltd had earlier been picked to lead the share sale, which was expected before the end of last year. WeDoctor was seeking to raise US$500 million to US$1 billion through its listing at the time.

The medical platform’s operations span insurance policies, medical supplies, online appointment-booking and clinics. The national healthcare operator, which covers more than 95 percent of the population, is working with the firm to provide insurance-covered health care.

READ MORE: Tencent-backed WeDoctor hiring new CFO to lead HK IPO

WeDoctor operated 16 facilities and 30 online internet hospitals, connecting 7,600 hospitals and 250,000 physicians as of October. It was valued at about US$5.5 billion in a 2018 funding round.

Chen was former CSO at WeDoctor before he joined Fullerton Health as chief innovation officer and head of capital markets, according to an announcement in February 2019. WeDoctor’s chief financial officer departed the company late last year.


Share this story

CHINA DAILY
HONG KONG NEWS
OPEN
Please click in the upper right corner to open it in your browser !